Vastarel 20

Vastarel 20

trimetazidine

Manufacturer:

Servier

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Trimetazidine diHCl
Indications/Uses
Add-on therapy for symptomatic treatment in adults w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line antianginal therapies.
Dosage/Direction for Use
1 tab tds. Moderate renal impairment (CrCl 30-60 mL/min) 1 tab bd in the morning & evening.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Parkinson's disease, parkinsonian symptoms, tremors, restless leg syndrome or other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Special Precautions
Allergic reactions. Not a curative treatment for angina attacks or as initial treatment for unstable angina or MI. Not to be used in pre-hospital phase or during 1st days of hospitalisation. Discontinue use if movement disorders eg, parkinsonian symptoms, restless leg syndrome, tremors, gait instability occur. Falls related to gait instability & hypotension. May cause allergic reaction due to sunset yellow FCF (E110) & cochineal red A (E124). Positive result in anti-doping tests. May affect ability to drive & use machines. Moderate renal impairment. Not recommended during pregnancy & lactation. Childn <18 yr. Elderly >75 yr.
Adverse Reactions
Dizziness, headache; abdominal pain, diarrhoea, dyspepsia, nausea, vomiting; rash, pruritus, urticaria; asthenia.
MIMS Class
Anti-Anginal Drugs
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Vastarel 20 FC tab 20 mg
Packing/Price
60's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in